Table 2.
mPE n = 45; mPE+MET-PTSD n = 40; HLS n = 41 | ||||
---|---|---|---|---|
Baseline | End-of- treatment |
3-month | 6-month | |
IES-R | ||||
mPE | 48.56 (43.43–53.68) |
16.20a (10.48–21.92) |
14.11a (8.33–19.90) |
16.45a (10.85–22.06) |
mPE+MET- PTSD |
54.95 (49.51–60.39) |
20.49a (14.77–26.20) |
19.10a (13.01–25.18) |
20.48 (14.53–26.42) |
HLS | 51.02 (45.65–56.40) |
27.40b (21.80–33.01) |
26.00b (20.15–31.85) |
26.50b (20.52–32.50) |
BDI-II | ||||
mPE | 29.49 (26.48–32.49) |
7.08a (3.49–10.66) |
10.21a (5.90–14.51) |
6.60a (2.16–11.19) |
mPE+MET- PTSD |
32.40 (29.21–35.59) |
10.78 (7.07–14.50) |
14.34 (9.82–18.87) |
13.39b (8.49–18.30 |
HLS | 29.80 (26.61–32.90) |
13.33b (9.89–16.77) |
16.84b (12.94–20.73) |
13.59b (8.97–18.22) |
Alcohol PDA | ||||
PE | 46.13 (39.04–52.61) |
------ | 97.32 (90.76–103.87) |
94.49 (87.94–101.05) |
mPE+MET- PTSD |
48.70 (41.82–55.57) |
------ | 92.46 (85.66–99.25) |
85.73 (78.94–92.52) |
HLS | 52.23 (45.53–59.03) |
------ | 97.08 (90.28–103.88) |
93.58 (86.78–100.37) |
Drug PDA | ||||
mPE | 53.44 (46.87–60.01) |
------ | 97.52 (90.87–104.16) |
96.94 (90.87–104.16) |
mPE+MET- PTSD |
45.47 (38.50–52.43) |
------ | 93.37 (86.49–100.26) |
91.97 (85.08–98.85) |
HLS | 59.59 (52.71–66.48) |
------ | 97.94 (91.06–104.83) |
91.70 (84.82–98.59) |
ACQ | ||||
mPE | 143.65 (128.05–159.25) |
95.85 (78.58–113.12) |
103.15 (83.32–122.97) |
96.40 (75.89–116.91) |
mPE+MET- PTSD |
172.31 (155.93–188.69) |
114.23 (96.08–132.38) |
104.12 (83.66–124.57) |
95.63 (72.95–118.31) |
HLS | 145.45 (128.85–162.1) |
117.13 (100.00–134.26) |
109.34 (90.62–128.05) |
108.35 (87.26–129.44) |
Note: mPE = modified prolonged exposure; mPE+MET-PTSD = modified prolonged exposure plus trauma-focused motivation enhancement therapy; HLS = Healthy Lifestyle Sessions; IES-R = Impact of Event Scale-Revised; BDI-II = Beck Depression Inventory-II; PDA = percent days abstinent, ACQ = Alcohol Craving Questionnaire-Now.
Significant differences (≤ .05) between groups at each assessment point are denoted by unmatched letters (i.e., a and b).